Analysis10k / Blog
The Story · SNPS

Synopsys's Last Two Years: A Record Acquisition and a Self-Inflicted Wound, in the Same Quarter

The short answer

Synopsys closed its roughly $35 billion Ansys acquisition — the largest deal in its history — in the same quarter that China export controls, a major foundry customer's slowdown, and the company's own admitted execution mistakes forced a guidance cut and a 10% workforce reduction. Two years later, results are recovering, but confidence hasn't yet returned to where it stood before the crisis.

The story

2023: a stable three-segment leader

Through 2023, Synopsys was a steady EDA leader with three segments — Design Automation, Design IP, and Software Integrity (security/quality software) — each posting double-digit growth, with "another record revenue" repeated on nearly every earnings call. In January 2024, Sassine Ghazi became CEO, and that same year the company announced it would acquire engineering-simulation software maker Ansys for roughly $35 billion — the largest deal in company history, and in the engineering-software industry's history.

Reshaping itself to close the deal

Closing a deal this size required real restructuring. The FY2024 10-K's business description dropped from three segments to two — Software Integrity had been sold off entirely. At the same time, a brand-new risk category appeared: "Risks Related to the Ansys Merger," warning of a termination fee of up to $1.5 billion if the deal fell through, and flagging that significant new debt would follow. Early-2025 calls repeatedly said China would "slow to company-average levels" — language that, quarter by quarter, crept toward "below company average."

Everything hit at once

The real turning point came in Q3 FY2025 (September 2025). Just three months earlier, the company had said it had "received no notification from BIS" and held its annual guidance. This quarter, it confirmed an actual six-week China export restriction had hit, layered on top of a major foundry customer's demand slowdown — and, unusually, management admitted in its own 10-K that "some of our roadmap and resource allocation decisions did not yield their intended results." Annual guidance was cut and a 10% workforce reduction was announced. All of this landed in the same quarter the Ansys deal finally closed (July 2025) — integrating history's largest deal while one of its core businesses was cracking.

What else changed in the filings Regulators required Synopsys to divest its Optical Solutions Group to win antitrust approval for the Ansys deal — that sale to Keysight Technologies completed October 17, 2025. The Ansys-related risk language itself evolved from "we may fail to complete the merger" to, one year later, "the Ansys Merger, which was completed in July 2025... we had approximately $13.5 billion of total debt" — the character of the risk shifted from deal uncertainty to real, carried leverage.

A slow, still-incomplete recovery

Q4 FY2025 (December 2025) results beat the lowered guidance's top end slightly, but full-year China revenue finished down 18% (down 22% excluding Ansys) — far from the "company average" pace promised a year earlier. FY2026 guidance explicitly stated the company would "remain cautious on China." Q1 and Q2 FY2026 each beat guidance's top end, and Q2 raised revenue, margin, EPS, and free-cash-flow guidance all at once, with management saying Design IP had "bottomed in Q1 and recovery is beginning."

Our take, in one line These two years are really two overlapping stories — a successfully closed mega-merger building a new "silicon to systems" vision, and a much worse-than-expected China- and customer-driven crisis in the core business — that happened to peak in the exact same quarter.

Guidance scorecard

5 tracked promises, in order made
When setWhat was promisedWhat actually happenedResult
Q4 FY2024 → FY2025China to slow to "company-average" pace; double-digit revenue growthChina revenue -18% for the year; guidance itself was cut mid-yearMissed
Q2 FY2025"No notification from BIS," guidance heldReversed just one quarter later when export restrictions actually hitReversed quickly
Q3 FY2025 (lowered)FY2025 revenue $7.00B–$7.03BActual $7.05B; Q4 EPS slightly above guidanceMet (against lowered bar)
Q4 FY2025 → FY2026Revenue $9.56B–$9.66BQ1 FY2026 beat the top end; EPS raised $0.06Beat
Q1 FY2026 (reaffirmed)Full-year revenue/margin/cash-flow guidance heldQ2 FY2026 beat; revenue, margin, EPS, and FCF guidance all raisedBeat

4 of 5 tracked promises met or beaten; 1 (the China revenue outlook) clearly missed. Quarterly revenue and EPS guidance itself follows a fairly typical conservative-then-slight-beat pattern — but the China and export-control outlook specifically showed a repeated optimism-then-walk-back pattern.

Source: each earnings call's CFO guidance commentary, checked against 10-K FY2025 reported figures.

Timeline

  • Jan 2024Sassine Ghazi becomes CEO; Synopsys announces the ~$35B Ansys acquisition, the largest deal in company history.
  • FY2024Software Integrity segment sold off entirely — three segments become two.
  • Feb–May 2025China outlook language shifts from "company average" toward "below company average"; a BIS-restriction rumor breaks just before the Q2 call.
  • Jul 2025Ansys acquisition finally completes (adding ~$13.5B in debt); Optical Solutions Group divested to Keysight as a regulatory condition.
  • Sep 2025Q3 earnings: actual 6-week China export restriction confirmed, major foundry customer weakness, and an admitted internal execution mistake — guidance cut, 10% workforce reduction announced.
  • Dec 2025Q4/FY2025 close: beat the lowered guidance slightly; full-year China revenue down 18% (down 22% ex-Ansys).
  • Feb–May 2026Q1 and Q2 FY2026 both beat guidance's top end; Q2 raises revenue, margin, EPS, and FCF guidance together; Design IP described as bottoming and recovering.

Our read

The real story of these two years isn't simply "the merger closed" — it's that a historic acquisition and a genuine crisis in the core China/foundry business happened to collide in the same quarter, testing management's crisis-handling under maximum pressure. The last two quarters' guidance raises are clearly positive, but whether "recovery" reflects real demand improvement or just an easier year-over-year comparison base is something only the next two or three quarters can really confirm.

What we still don't know

  • The specific reasons behind the company's own admitted "roadmap and resource allocation" mistakes aren't detailed anywhere in the filings reviewed here.
  • Concrete progress on Ansys integration synergies (cost savings, cross-selling) would require the company's planned September 2026 Investor Day materials, outside this analysis's scope.
  • Whether China export controls will expand further or stabilize is a policy variable the company's own disclosures can't predict.
Built from 10-K filings for FY2023 through FY2025 and 8 quarters of earnings call transcripts from Q3 FY2024 (Aug 2024) through Q2 FY2026 (May 2026). Tone assessments are qualitative. This is a research summary, not investment advice.

Frequently asked questions

What was the Ansys acquisition?

Synopsys closed its roughly $35 billion acquisition of Ansys, the largest deal in its history, in the same quarter that China export controls and a major customer slowdown forced a guidance cut and 10% workforce reduction.

Has Synopsys recovered from that crisis?

Partially — results have been recovering over the two years since, but management's confidence and tone hadn't yet returned to where they stood before the crisis, as of the most recent quarters reviewed.

What sources does this analysis draw from?

This piece is built from Synopsys's 10-K filings for FY2023 through FY2025 and 8 quarters of earnings call transcripts from August 2024 to May 2026.